Document 6557151

 Amie Joyce, MPH, Joins RxAnte as Vice President, Account
Management
Company Expands Executive Leadership Team
McLean, Va. – Oct. 7, 2014 – RxAnte, LLC, the leading platform for improving medication use through
predictive analytics and targeted clinical programs, today announced Amie Joyce, MPH, as Vice President of
Account Management. Ms. Joyce will also join the Company’s leadership team.
“RxAnte is in the midst of significant growth, and it is important to continue to meet the evolving needs of
our clients by providing data-driven insights and innovations that improve the use of prescription medications
for the patients they serve,” said Aaron McKethan, PhD, President of RxAnte. “Amie is an excellent addition
to our Company and our leadership team. With her assistance, RxAnte will continue to achieve our corporate
mission to make a difference for patients, clients, and partners across the healthcare landscape.”
Ms. Joyce adds, “I am thrilled to join RxAnte and look forward to meeting the needs of RxAnte’s growing
list of partners by delivering excellent client service and innovative solutions.”
Ms. Joyce has 20 years of experience in healthcare analytics, account management, and consulting with
health plans, PBMs, pharmaceutical companies, and others in the healthcare industry. Prior to joining
RxAnte, she led the account management function within the Payer and Provider division of IMS Health. She
also was responsible for the management of key pharmaceutical accounts and has designed and conducted
numerous health-economic and epidemiologic evaluations while at PharMetrics, Inc. (acquired by IMS). Prior
to that, Ms. Joyce managed a research analytics group for Merck-Medco (now Express Scripts), which was
responsible for evaluations of disease management and intervention programs for both internal and external
audiences and the pharmaceutical industry. Ms. Joyce holds an MPH in epidemiology and biostatistics from
Yale University School of Medicine, and a BA in mathematics from Boston College.
About RxAnte
RxAnte is the leading platform for improving medication use and drug therapy outcomes through predictive
analytics and targeted clinical programs. Its innovative analytics platform is transforming how organizations
work with healthcare professionals, care management intervention providers, and patients to promote the safe
and effective use of prescription medications. Created by medication adherence, health IT, and advanced
analytics experts, the “RxAnte System” is a patent-pending platform that includes predictive and decision
analytics, advanced evaluation methods, and an innovative platform for provider engagement. Learn more at
www.rxante.com or follow us on Twitter.
Contact
RxAnte, LLC
Heather Mills
6862 Elm Street, Suite 320
McLean, VA 22101
Phone: 571.386.8439
[email protected]
###
RX Press Release (Amie Joyce) (10.7.2014)[1].docx